Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration

Enrofloxacin (ENR) is widely used for treatment and prevention of bacterial pathogen infections in aquatic animals. However, limited knowledge on kinetic disposal process of ENR in crayfish (Procambrus clarkii). Therefore, the objective of this study was to explore the pharmacokinetics (PK) and tiss...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yong-Tao Liu, Guo-Dong Zhang, Ru-Yu Sun, Shu Zhou, Jing Dong, Yi-Bin Yang, Qiu-Hong Yang, Ning Xu, Xiao-Hui Ai
Formato: article
Lenguaje:EN
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://doaj.org/article/a38392ad8100416d8cf15a07cf304ac4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a38392ad8100416d8cf15a07cf304ac4
record_format dspace
spelling oai:doaj.org-article:a38392ad8100416d8cf15a07cf304ac42021-11-10T04:28:47ZDetermination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration2352-513410.1016/j.aqrep.2021.100939https://doaj.org/article/a38392ad8100416d8cf15a07cf304ac42022-02-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352513421003562https://doaj.org/toc/2352-5134Enrofloxacin (ENR) is widely used for treatment and prevention of bacterial pathogen infections in aquatic animals. However, limited knowledge on kinetic disposal process of ENR in crayfish (Procambrus clarkii). Therefore, the objective of this study was to explore the pharmacokinetics (PK) and tissue distribution regularities of ENR and its predominate metabolite, ciprofloxian (CIP), in crayfish following oral (PO) and intramuscular (IM) administrations. ENR and CIP concentrations in crayfish hemolymph and tissues were determined using ultra performance liquid chromatography coupled to fluorescence detection (UPLC-FLR). PK parameters of targets in hemolymph and tissues were calculated using WinNolin software based on the non-compartmental analysis. Comparative PK parameters in hemolymph showed that higher absorption and longer elimination half-life following IM route than PO treatment. For tissue distribution, high concentrations of ENR and CIP were found in hepatopancreas, and ENR and CIP levels in tissues after IM administration were higher than PO administration. The AUC0-∞ ratios of CIP and ENR in crayfish following PO and IM routes were only 1.25% and 3.56% (hemolymph), 0.71% and 6.89% (muscle), 1.03% and 1.75% (hepatopancreas), 0.65% and 6.46% (gill), respectively, and it indicated that crayfish has a low ability to transform ENR to CIP. ENR regimen suggested against susceptible strains with the minimum inhibition concentration (MIC) below 0.72 μg/mL (IM) and 0.50 μg/mL (PO) based on the values of Cmax/MIC > 8 and AUC/MIC > 125. It could serve as reference data for ENR use in crayfish and provide valuable information for the better utilization of ENR in aquatic animals.Yong-Tao LiuGuo-Dong ZhangRu-Yu SunShu ZhouJing DongYi-Bin YangQiu-Hong YangNing XuXiao-Hui AiElsevierarticleCrayfishEnrofloxacinCiprofloxacinPharmacokineticsTissue distributionAquaculture. Fisheries. AnglingSH1-691ENAquaculture Reports, Vol 22, Iss , Pp 100939- (2022)
institution DOAJ
collection DOAJ
language EN
topic Crayfish
Enrofloxacin
Ciprofloxacin
Pharmacokinetics
Tissue distribution
Aquaculture. Fisheries. Angling
SH1-691
spellingShingle Crayfish
Enrofloxacin
Ciprofloxacin
Pharmacokinetics
Tissue distribution
Aquaculture. Fisheries. Angling
SH1-691
Yong-Tao Liu
Guo-Dong Zhang
Ru-Yu Sun
Shu Zhou
Jing Dong
Yi-Bin Yang
Qiu-Hong Yang
Ning Xu
Xiao-Hui Ai
Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
description Enrofloxacin (ENR) is widely used for treatment and prevention of bacterial pathogen infections in aquatic animals. However, limited knowledge on kinetic disposal process of ENR in crayfish (Procambrus clarkii). Therefore, the objective of this study was to explore the pharmacokinetics (PK) and tissue distribution regularities of ENR and its predominate metabolite, ciprofloxian (CIP), in crayfish following oral (PO) and intramuscular (IM) administrations. ENR and CIP concentrations in crayfish hemolymph and tissues were determined using ultra performance liquid chromatography coupled to fluorescence detection (UPLC-FLR). PK parameters of targets in hemolymph and tissues were calculated using WinNolin software based on the non-compartmental analysis. Comparative PK parameters in hemolymph showed that higher absorption and longer elimination half-life following IM route than PO treatment. For tissue distribution, high concentrations of ENR and CIP were found in hepatopancreas, and ENR and CIP levels in tissues after IM administration were higher than PO administration. The AUC0-∞ ratios of CIP and ENR in crayfish following PO and IM routes were only 1.25% and 3.56% (hemolymph), 0.71% and 6.89% (muscle), 1.03% and 1.75% (hepatopancreas), 0.65% and 6.46% (gill), respectively, and it indicated that crayfish has a low ability to transform ENR to CIP. ENR regimen suggested against susceptible strains with the minimum inhibition concentration (MIC) below 0.72 μg/mL (IM) and 0.50 μg/mL (PO) based on the values of Cmax/MIC > 8 and AUC/MIC > 125. It could serve as reference data for ENR use in crayfish and provide valuable information for the better utilization of ENR in aquatic animals.
format article
author Yong-Tao Liu
Guo-Dong Zhang
Ru-Yu Sun
Shu Zhou
Jing Dong
Yi-Bin Yang
Qiu-Hong Yang
Ning Xu
Xiao-Hui Ai
author_facet Yong-Tao Liu
Guo-Dong Zhang
Ru-Yu Sun
Shu Zhou
Jing Dong
Yi-Bin Yang
Qiu-Hong Yang
Ning Xu
Xiao-Hui Ai
author_sort Yong-Tao Liu
title Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
title_short Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
title_full Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
title_fullStr Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
title_full_unstemmed Determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in Procambarus clarkii after two routes of administration
title_sort determination of pharmacokinetic parameters and tissue distribution characters of enrofloxacin and its metabolite ciprofloxacin in procambarus clarkii after two routes of administration
publisher Elsevier
publishDate 2022
url https://doaj.org/article/a38392ad8100416d8cf15a07cf304ac4
work_keys_str_mv AT yongtaoliu determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT guodongzhang determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT ruyusun determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT shuzhou determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT jingdong determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT yibinyang determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT qiuhongyang determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT ningxu determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
AT xiaohuiai determinationofpharmacokineticparametersandtissuedistributioncharactersofenrofloxacinanditsmetaboliteciprofloxacininprocambarusclarkiiaftertworoutesofadministration
_version_ 1718440680904196096